Results 141 to 150 of about 51,044 (202)

Novel assays to assess the prevalence and neutralizing potential of anti-IdeS antibodies in healthy humans. [PDF]

open access: yesFront Immunol
Hannachi E   +9 more
europepmc   +1 more source

Therapeutic IgG- and IgM-specific proteases disarm the acetylcholine receptor autoantibodies that drive myasthenia gravis pathology. [PDF]

open access: yesProc Natl Acad Sci U S A
Bayer AC   +16 more
europepmc   +1 more source

Phase Ia study to evaluate RO7497987, a FLT3L-fragment Fc fusion protein, in healthy volunteers. [PDF]

open access: yesFront Immunol
Iacovelli AJ   +9 more
europepmc   +1 more source

Reduced Fc-mediated antibody responses after COVID-19 mRNA vaccination in a cohort of people living with HIV-1. [PDF]

open access: yesSci Rep
Klingler J   +12 more
europepmc   +1 more source

Impairment by glycation of immunoglobulin G Fc fragment function

Scandinavian Journal of Clinical and Laboratory Investigation, 1990
Incubation of human immunoglobulin G (IgG) with glucose in vitro leads to the formation of glycated IgG concomitant with marked changes in functional properties of the Fc fragment. After 22 days of incubation in the absence and presence of 13.9, 27.7 and 55.5 mmol/l glucose, respectively, protein A binding was reduced by 42, 66 and 83%, depending on ...
R, Dolhofer-Bliesener, K D, Gerbitz
openaire   +2 more sources

Home - About - Disclaimer - Privacy